Q&M unit's PCR tests can detect Omicron variant

Published Fri, Dec 3, 2021 · 01:05 AM

    DENTAL group Q&M QC7 on Friday (Dec 3) announced that polymerase chain reaction (PCR) test kits developed by its subsidiary, Acumen Diagnostics, are capable of detecting Covid-positive cases of the new variant Omicron.

    In addition to the Delta variant, the home-grown medical technology company's 2 PCR test kits, Acu-Corona 2.0 and Acu-Corona Duplex, can also detect Omicron.

    As the PCR test kits are locally manufactured, they can be deployed quickly and more efficiently. Q&M Dental Group has highlighted Acumen's cost-effectiveness and greater self-sufficiency compared to that of its peers imported from overseas.

    Acumen currently operates 2 laboratories that can process 7,000 diagnostic tests on a daily basis.

    Ong Siew Hwa, executive director of Aoxin Q&M Dental, and chief executive officer and chief scientist of Acumen Diagnostics, is confident of Acumen's PCR tests in detecting the new, highly infectious variant.

    She said: "With PCR tests remaining the gold standard to detect Covid-19, Acumen remains well-positioned to help Singapore tackle this new challenge posed by the virus, with our effective and affordable PCR test kits that are equipped to detect Covid-19 positive cases infected with Delta and Omicron, as well as our laboratory testing capabilities that can run 7,000 tests daily."

    BT in your inbox

    Start and end each day with the latest news stories and analyses delivered straight to your inbox.

    Acumen is a 51 per cent-owned subsidiary of Q&M and 49 per cent owned by Aoxin Q&M 1D4 . It is one of the few companies in Singapore with proprietary technology in testing for Covid-19.

    Catalist-listed Aoxin Q&M acquired Acumen in early October. Acumen focuses on expanding technical capabilities in the areas of molecular diagnostics and clinical laboratory testing for infectious diseases, cancer and Covid-19.

    Shares of Q&M closed at S$0.62 on Thursday (Dec 2), down S$0.015 or 2.4 per cent, before the announcement, while shares of Aoxin Q&M closed at S$0.24, down S$0.005 or 2 per cent.

    READ MORE:

    Copyright SPH Media. All rights reserved.